Search

everythinglearnresearchcommunity

for

Search:↓

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

People with alopecia areata may have a higher risk of thyroid diseases.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Alopecia areata patients often have other autoimmune diseases, especially women with nail issues or atopic diseases.

High prolactin levels might be linked to hair loss in autoimmune thyroid disease, but more research is needed.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

Graves' disease can cause hair loss in children and should be considered when treating pediatric alopecia areata.

Women with thyroid disease are more likely to experience female pattern hair loss, especially if they've had thyroid disease for a long time.

Certain types of alopecia areata are linked to allergies, autoimmune diseases, and family history.

Personalized treatment considering atopic status and cytokine profiles may help in managing pediatric alopecia areata.

Different diseases cause specific skin and hair follicle changes in dogs with alopecia.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Alopecia Areata might be linked to Crohn's disease.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Some treatments for multiple sclerosis can cause hair loss.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Alopecia areata patients need better education to improve their disease management.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

People with alopecia have a higher risk of thyroid cancer.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Hair loss linked to heart disease in young men.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

People with androgenetic alopecia may have a higher genetic risk for cardiovascular diseases.

FUE successfully restored hair growth in a patient with alopecia from Hansen's disease.